{"data":{"id":"us/21-cfr-640.94","jurisdiction":"us","citation":"21 CFR 640.94","heading":"Labeling.","body":"In addition to the labeling requirements of §§ 610.60, 610.61, and 610.62 of this chapter, the container and package labels shall contain the following information:\n(a) The osmotic equivalent in terms of plasma, and the sodium concentration in terms of a value or a range in milliequivalents per liter.\n(b) The cautionary statement placed in a prominent position on the label, “Do Not Use if Turbid. Do Not Begin Administration More than 4 Hours After the Container Has Been Entered.”","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER F—BIOLOGICS","PART 640—ADDITIONAL STANDARDS FOR HUMAN BLOOD AND BLOOD PRODUCTS","Subpart I—Plasma Protein Fraction (Human)"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"dca839bc28c3d4db880ada292530022e08c0dd1a2a4e24054c5f8a27afae7a3e","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-640.93","next":"us/21-cfr-640.100"},"notice":"GroundRules: Original legal text. Not legal advice."}